Carbon
is a Massachusetts-based biotechnology company that develops and commercializes novel parvovirus gene therapies for the treatment of lung disease... Read moreCarbon
is a Massachusetts-based biotechnology company that develops and commercializes novel parvovirus gene therapies for the treatment of lung disease... Read more
News
May 02, 2024
PR Newswire
Press Release: Carbon : Carbon Biosciences Announces Four Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Jun 28, 2022
Global Legal Chronicle
Carbon: Carbon Biosciences' $38 Million Series A Financing
Jun 23, 2022
The Business Journals
Carbon: The Petri Dish: Longwood Fund unveils $38M gene therapy startup
Jun 22, 2022
Cyber News
Carbon: A biotech startup launches with $38M to develop a cystic fibrosis gene therapy - BioPharma Dive
Jun 22, 2022
Equal Ocean
Carbon: Gene therapy company carbon completed a round of financing of USD 38million
Jun 22, 2022
Startup Around
Carbon: Carbon Biosciences Raises $38M in Series A Financing
Jun 21, 2022
FirstWord Pharma
Carbon: Cystic Fibrosis Foundation Invests $6M in Carbon Biosciences to Advance New Gene Therapy Approach for Cystic Fibrosis
Jun 21, 2022
BioCentury
Carbon: Carbon: a non-AAV gene therapy for cystic fibrosis with repeat dosing potential
